Weekly Signal Report — May 10, 2026

📉 38 crossed below 📈 33 recovered

This week, 38 stocks crossed below their 200-week moving average — entering what we call “deep value territory.” This is the signal our screener is built to detect: quality companies trading below a price level that has historically represented a floor over the prior four years.

Not every stock that crosses the line is a buy. Some are cheap for good reason. The 200-week moving average is a starting point for research, not a buy signal. Below, we break down each new crossing with the context you need to decide whether it’s opportunity or a warning.

On the other side, 33 stocks climbed back above the line this week — exiting deep value territory.

What is deep value territory?

The 200-week moving average represents roughly four years of price history. When a stock drops below this level, it means the current price is lower than the average investor paid over the last four years. For quality companies, these moments are rare — most stocks only cross below the 200-week line a handful of times in their history.

Our data shows that while 12-month returns from a crossing can be modest, 24-month returns are often significantly higher. The strategy requires patience. Not every crossing is a buying opportunity — some stocks are cheap because the business is deteriorating. That's why we pair the signal with quality metrics like free cash flow trends, insider buying, and return on equity.

📉 Newly Below the Line

TMDX — TransMedics Group, Inc.

Healthcare - Organ Transplant Technology $2.3B
26.7% below $67.79 → 200WMA $92.54

Historical Context

This is the 6th time TMDX has crossed below its 200-week moving average. Previous crossings produced an average 1-year return of +170.9%. History favors the patient buyer here.

Quality Signals

📉 RSI 25 (Oversold) 💥 Capitulation Volume

No quality flags detected. This stock crossed below the line without any of our positive quality signals — approach with extra caution.

Things to Watch

  • Oversold (RSI 25): The stock is already deeply oversold on a weekly basis. This could mean a bounce is near, but it could also mean momentum is strongly negative. Don't catch a falling knife without a thesis.
  • No quality floor: This stock doesn't pass our Buffett quality screen or have a long dividend track record. The business quality is less certain, which means the 200-week MA crossing carries less predictive weight.
  • The 200-week moving average is a starting point, not a buy signal. Always research the company's fundamentals, competitive position, and recent news before acting.
View full TMDX analysis →

ADMA — ADMA Biologics, Inc.

Healthcare - Biotechnology $1.9B
21.9% below $8.17 → 200WMA $10.46

Historical Context

This is the 7th time ADMA has crossed below its 200-week moving average. Previous crossings produced an average 1-year return of -23.3%. History has not rewarded buying this stock at the 200-week line — extra caution warranted.

Quality Signals

📉 RSI 16 (Oversold) 🔄 Frequent Crosser — Weak Recoveries 💥 Capitulation Volume

No quality flags detected. This stock crossed below the line without any of our positive quality signals — approach with extra caution.

Things to Watch

  • Oversold (RSI 16): The stock is already deeply oversold on a weekly basis. This could mean a bounce is near, but it could also mean momentum is strongly negative. Don't catch a falling knife without a thesis.
  • Cycling pattern: ADMA has crossed below the 200-week MA 7 times with modest average returns. This stock may oscillate around the line rather than bounce decisively — consider whether this is a value trap.
  • No quality floor: This stock doesn't pass our Buffett quality screen or have a long dividend track record. The business quality is less certain, which means the 200-week MA crossing carries less predictive weight.
  • The 200-week moving average is a starting point, not a buy signal. Always research the company's fundamentals, competitive position, and recent news before acting.
View full ADMA analysis →

SHAK — Shake Shack Inc.

Consumer Discretionary - Restaurants $3.0B
17.4% below $70.14 → 200WMA $84.94

Historical Context

This is the 14th time SHAK has crossed below its 200-week moving average. Previous crossings produced an average 1-year return of +49.1%. History favors the patient buyer here.

Quality Signals

💥 Capitulation Volume

No quality flags detected. This stock crossed below the line without any of our positive quality signals — approach with extra caution.

Things to Watch

  • No quality floor: This stock doesn't pass our Buffett quality screen or have a long dividend track record. The business quality is less certain, which means the 200-week MA crossing carries less predictive weight.
  • The 200-week moving average is a starting point, not a buy signal. Always research the company's fundamentals, competitive position, and recent news before acting.
View full SHAK analysis →

CSTL — Castle Biosciences, Inc.

Healthcare - Diagnostics & Research $601M
17.2% below $19.83 → 200WMA $23.96

Historical Context

This is the third time CSTL has crossed below its 200-week moving average. Previous crossings produced an average 1-year return of -55.8%. History has not rewarded buying this stock at the 200-week line — extra caution warranted.

Quality Signals

📉 RSI 15 (Oversold) 🔄 Frequent Crosser — Weak Recoveries 💥 Capitulation Volume

No quality flags detected. This stock crossed below the line without any of our positive quality signals — approach with extra caution.

Things to Watch

  • Oversold (RSI 15): The stock is already deeply oversold on a weekly basis. This could mean a bounce is near, but it could also mean momentum is strongly negative. Don't catch a falling knife without a thesis.
  • No quality floor: This stock doesn't pass our Buffett quality screen or have a long dividend track record. The business quality is less certain, which means the 200-week MA crossing carries less predictive weight.
  • The 200-week moving average is a starting point, not a buy signal. Always research the company's fundamentals, competitive position, and recent news before acting.
View full CSTL analysis →

WLK — Westlake Corporation

Materials - Chemicals $12.0B
13.7% below $93.85 → 200WMA $108.73

Historical Context

This is the 18th time WLK has crossed below its 200-week moving average. Previous crossings produced an average 1-year return of +6.4%. History favors the patient buyer here.

Quality Signals

⚠️ FCF Declining

No quality flags detected. This stock crossed below the line without any of our positive quality signals — approach with extra caution.

Things to Watch

  • RSI still elevated (57): The stock just crossed below the line but isn't oversold yet. It may have further to fall before reaching a bottom.
  • Cash flow is deteriorating: Free cash flow is trending downward. The stock might be cheap for a reason — verify whether this is a temporary or structural issue.
  • Cycling pattern: WLK has crossed below the 200-week MA 18 times with modest average returns. This stock may oscillate around the line rather than bounce decisively — consider whether this is a value trap.
  • No quality floor: This stock doesn't pass our Buffett quality screen or have a long dividend track record. The business quality is less certain, which means the 200-week MA crossing carries less predictive weight.
  • The 200-week moving average is a starting point, not a buy signal. Always research the company's fundamentals, competitive position, and recent news before acting.
View full WLK analysis →

TROX — Tronox Holdings plc

Materials - Titanium Dioxide $1.4B
13% below $8.82 → 200WMA $10.14

Historical Context

This is the 17th time TROX has crossed below its 200-week moving average. Previous crossings produced an average 1-year return of -14.5%. History has not rewarded buying this stock at the 200-week line — extra caution warranted.

Quality Signals

⚠️ FCF Declining 🔄 Frequent Crosser — Weak Recoveries

No quality flags detected. This stock crossed below the line without any of our positive quality signals — approach with extra caution.

Things to Watch

  • RSI still elevated (64): The stock just crossed below the line but isn't oversold yet. It may have further to fall before reaching a bottom.
  • Cash flow is deteriorating: Free cash flow is trending downward. The stock might be cheap for a reason — verify whether this is a temporary or structural issue.
  • Cycling pattern: TROX has crossed below the 200-week MA 17 times with modest average returns. This stock may oscillate around the line rather than bounce decisively — consider whether this is a value trap.
  • No quality floor: This stock doesn't pass our Buffett quality screen or have a long dividend track record. The business quality is less certain, which means the 200-week MA crossing carries less predictive weight.
  • The 200-week moving average is a starting point, not a buy signal. Always research the company's fundamentals, competitive position, and recent news before acting.
View full TROX analysis →

NCLH — Norwegian Cruise Line Holdings Ltd.

Consumer Discretionary - Cruise Lines $7.8B
9.1% below $17.08 → 200WMA $18.79

Historical Context

This is the 20th time NCLH has crossed below its 200-week moving average. Previous crossings produced an average 1-year return of +21%. History favors the patient buyer here.

Quality Signals

🔍 Insider Buying

Things to Watch

  • No quality floor: This stock doesn't pass our Buffett quality screen or have a long dividend track record. The business quality is less certain, which means the 200-week MA crossing carries less predictive weight.
  • The 200-week moving average is a starting point, not a buy signal. Always research the company's fundamentals, competitive position, and recent news before acting.
View full NCLH analysis →

RGR — Sturm, Ruger & Company, Inc.

Industrials - Firearms $622M
9.1% below $39.04 → 200WMA $42.93

Historical Context

This is the 26th time RGR has crossed below its 200-week moving average. Previous crossings produced an average 1-year return of +16.5%. History favors the patient buyer here.

Quality Signals

🎯 Yartseva Multibagger 💰 5.7% FCF Yield

Things to Watch

  • RSI still elevated (58): The stock just crossed below the line but isn't oversold yet. It may have further to fall before reaching a bottom.
  • No quality floor: This stock doesn't pass our Buffett quality screen or have a long dividend track record. The business quality is less certain, which means the 200-week MA crossing carries less predictive weight.
  • The 200-week moving average is a starting point, not a buy signal. Always research the company's fundamentals, competitive position, and recent news before acting.
View full RGR analysis →

PPC — Pilgrim's Pride Corporation

Consumer Staples - Poultry $6.9B
7.7% below $29.10 → 200WMA $31.51

Historical Context

This is the 28th time PPC has crossed below its 200-week moving average. Previous crossings produced an average 1-year return of +30.6%. History favors the patient buyer here.

Quality Signals

📉 RSI 16 (Oversold)

No quality flags detected. This stock crossed below the line without any of our positive quality signals — approach with extra caution.

Things to Watch

  • Oversold (RSI 16): The stock is already deeply oversold on a weekly basis. This could mean a bounce is near, but it could also mean momentum is strongly negative. Don't catch a falling knife without a thesis.
  • No quality floor: This stock doesn't pass our Buffett quality screen or have a long dividend track record. The business quality is less certain, which means the 200-week MA crossing carries less predictive weight.
  • The 200-week moving average is a starting point, not a buy signal. Always research the company's fundamentals, competitive position, and recent news before acting.
View full PPC analysis →

TOST — Toast, Inc.

Technology - Restaurant Software $14.5B
7.7% below $25.05 → 200WMA $27.13

Historical Context

This is the 5th time TOST has crossed below its 200-week moving average. Previous crossings produced an average 1-year return of +59.3%. History favors the patient buyer here.

Quality Signals

🏆 Buffett Quality

Things to Watch

  • The 200-week moving average is a starting point, not a buy signal. Always research the company's fundamentals, competitive position, and recent news before acting.
View full TOST analysis →

DBI — Designer Brands Inc.

Consumer Cyclical - Footwear & Accessories $354M
6.4% below $6.97 → 200WMA $7.45

Historical Context

This is the 14th time DBI has crossed below its 200-week moving average. Previous crossings produced an average 1-year return of -13.1%. History has not rewarded buying this stock at the 200-week line — extra caution warranted.

Quality Signals

🎯 Yartseva Multibagger 💰 17.6% FCF Yield ⚠️ FCF Declining 🔄 Frequent Crosser — Weak Recoveries

Things to Watch

  • RSI still elevated (55): The stock just crossed below the line but isn't oversold yet. It may have further to fall before reaching a bottom.
  • Cash flow is deteriorating: Free cash flow is trending downward. The stock might be cheap for a reason — verify whether this is a temporary or structural issue.
  • Cycling pattern: DBI has crossed below the 200-week MA 14 times with modest average returns. This stock may oscillate around the line rather than bounce decisively — consider whether this is a value trap.
  • No quality floor: This stock doesn't pass our Buffett quality screen or have a long dividend track record. The business quality is less certain, which means the 200-week MA crossing carries less predictive weight.
  • The 200-week moving average is a starting point, not a buy signal. Always research the company's fundamentals, competitive position, and recent news before acting.
View full DBI analysis →

DOW — Dow Inc.

Materials - Chemicals $26.6B
6.4% below $36.87 → 200WMA $39.39

Historical Context

This is the 6th time DOW has crossed below its 200-week moving average. Previous crossings produced an average 1-year return of -1.2%. History has not rewarded buying this stock at the 200-week line — extra caution warranted.

Quality Signals

⚠️ FCF Declining 🔄 Frequent Crosser — Weak Recoveries

No quality flags detected. This stock crossed below the line without any of our positive quality signals — approach with extra caution.

Things to Watch

  • RSI still elevated (65): The stock just crossed below the line but isn't oversold yet. It may have further to fall before reaching a bottom.
  • Cash flow is deteriorating: Free cash flow is trending downward. The stock might be cheap for a reason — verify whether this is a temporary or structural issue.
  • Cycling pattern: DOW has crossed below the 200-week MA 6 times with modest average returns. This stock may oscillate around the line rather than bounce decisively — consider whether this is a value trap.
  • No quality floor: This stock doesn't pass our Buffett quality screen or have a long dividend track record. The business quality is less certain, which means the 200-week MA crossing carries less predictive weight.
  • The 200-week moving average is a starting point, not a buy signal. Always research the company's fundamentals, competitive position, and recent news before acting.
View full DOW analysis →

RVLV — Revolve Group Inc.

Consumer Discretionary - E-Commerce $1.5B
6.3% below $20.86 → 200WMA $22.27

Historical Context

This is the 6th time RVLV has crossed below its 200-week moving average. Previous crossings produced an average 1-year return of +116.2%. History favors the patient buyer here.

Quality Signals

📈 FCF Growing

Things to Watch

  • No quality floor: This stock doesn't pass our Buffett quality screen or have a long dividend track record. The business quality is less certain, which means the 200-week MA crossing carries less predictive weight.
  • The 200-week moving average is a starting point, not a buy signal. Always research the company's fundamentals, competitive position, and recent news before acting.
View full RVLV analysis →

ANF — Abercrombie & Fitch Co.

Consumer Discretionary - Apparel Retail $3.5B
6% below $77.99 → 200WMA $82.97

Historical Context

This is the 25th time ANF has crossed below its 200-week moving average. Previous crossings produced an average 1-year return of +46%. History favors the patient buyer here.

Quality Signals

💰 7.5% FCF Yield

Things to Watch

  • No quality floor: This stock doesn't pass our Buffett quality screen or have a long dividend track record. The business quality is less certain, which means the 200-week MA crossing carries less predictive weight.
  • The 200-week moving average is a starting point, not a buy signal. Always research the company's fundamentals, competitive position, and recent news before acting.
View full ANF analysis →

GSBD — Goldman Sachs BDC, Inc.

Financial Services - BDC $1.0B
5.5% below $9.28 → 200WMA $9.82

Historical Context

This is the 14th time GSBD has crossed below its 200-week moving average. Previous crossings produced an average 1-year return of +18.4%. History favors the patient buyer here.

Quality Signals

🎯 Yartseva Multibagger 📈 FCF Growing 💰 9.2% FCF Yield

Things to Watch

  • RSI still elevated (53): The stock just crossed below the line but isn't oversold yet. It may have further to fall before reaching a bottom.
  • No quality floor: This stock doesn't pass our Buffett quality screen or have a long dividend track record. The business quality is less certain, which means the 200-week MA crossing carries less predictive weight.
  • The 200-week moving average is a starting point, not a buy signal. Always research the company's fundamentals, competitive position, and recent news before acting.
View full GSBD analysis →

CRK — Comstock Resources, Inc.

Energy - Oil & Gas E&P $4.1B
5.4% below $14.10 → 200WMA $14.91

Historical Context

This is the 28th time CRK has crossed below its 200-week moving average. Previous crossings produced an average 1-year return of +6.2%. History favors the patient buyer here.

Quality Signals

⚠️ FCF Declining 📉 RSI 27 (Oversold)

No quality flags detected. This stock crossed below the line without any of our positive quality signals — approach with extra caution.

Things to Watch

  • Oversold (RSI 27): The stock is already deeply oversold on a weekly basis. This could mean a bounce is near, but it could also mean momentum is strongly negative. Don't catch a falling knife without a thesis.
  • Cash flow is deteriorating: Free cash flow is trending downward. The stock might be cheap for a reason — verify whether this is a temporary or structural issue.
  • Cycling pattern: CRK has crossed below the 200-week MA 28 times with modest average returns. This stock may oscillate around the line rather than bounce decisively — consider whether this is a value trap.
  • No quality floor: This stock doesn't pass our Buffett quality screen or have a long dividend track record. The business quality is less certain, which means the 200-week MA crossing carries less predictive weight.
  • The 200-week moving average is a starting point, not a buy signal. Always research the company's fundamentals, competitive position, and recent news before acting.
View full CRK analysis →

NVST — Envista Holdings Corporation

Healthcare - Medical Instruments & Supplies $3.9B
5.1% below $24.24 → 200WMA $25.53

Historical Context

This is the 8th time NVST has crossed below its 200-week moving average. Previous crossings produced an average 1-year return of +3%. History favors the patient buyer here.

Quality Signals

📈 FCF Growing 💰 5.5% FCF Yield 🔄 Frequent Crosser — Weak Recoveries 💥 Capitulation Volume

Things to Watch

  • RSI still elevated (52): The stock just crossed below the line but isn't oversold yet. It may have further to fall before reaching a bottom.
  • Cycling pattern: NVST has crossed below the 200-week MA 8 times with modest average returns. This stock may oscillate around the line rather than bounce decisively — consider whether this is a value trap.
  • No quality floor: This stock doesn't pass our Buffett quality screen or have a long dividend track record. The business quality is less certain, which means the 200-week MA crossing carries less predictive weight.
  • The 200-week moving average is a starting point, not a buy signal. Always research the company's fundamentals, competitive position, and recent news before acting.
View full NVST analysis →

AHCO — AdaptHealth Corp.

Healthcare - Medical Devices $1.5B
4.8% below $11.30 → 200WMA $11.87

Historical Context

This is the 7th time AHCO has crossed below its 200-week moving average. Previous crossings produced an average 1-year return of +8%. History favors the patient buyer here.

Quality Signals

🎯 Yartseva Multibagger 🔍 Insider Buying 💰 17.4% FCF Yield

Things to Watch

  • RSI still elevated (56): The stock just crossed below the line but isn't oversold yet. It may have further to fall before reaching a bottom.
  • Cycling pattern: AHCO has crossed below the 200-week MA 7 times with modest average returns. This stock may oscillate around the line rather than bounce decisively — consider whether this is a value trap.
  • No quality floor: This stock doesn't pass our Buffett quality screen or have a long dividend track record. The business quality is less certain, which means the 200-week MA crossing carries less predictive weight.
  • The 200-week moving average is a starting point, not a buy signal. Always research the company's fundamentals, competitive position, and recent news before acting.
View full AHCO analysis →

PCVX — Vaxcyte Inc.

Healthcare - Biotechnology $7.7B
4.5% below $53.01 → 200WMA $55.51

Historical Context

This is the 4th time PCVX has crossed below its 200-week moving average. Previous crossings produced an average 1-year return of +59.4%. History favors the patient buyer here.

Quality Signals

⚠️ FCF Declining 💥 Capitulation Volume

No quality flags detected. This stock crossed below the line without any of our positive quality signals — approach with extra caution.

Things to Watch

  • Cash flow is deteriorating: Free cash flow is trending downward. The stock might be cheap for a reason — verify whether this is a temporary or structural issue.
  • No quality floor: This stock doesn't pass our Buffett quality screen or have a long dividend track record. The business quality is less certain, which means the 200-week MA crossing carries less predictive weight.
  • The 200-week moving average is a starting point, not a buy signal. Always research the company's fundamentals, competitive position, and recent news before acting.
View full PCVX analysis →

MGEE — MGE Energy, Inc.

Utilities - Utilities - Regulated Electric $2.8B
4.4% below $73.65 → 200WMA $77.07

Historical Context

This is the 30th time MGEE has crossed below its 200-week moving average. Previous crossings produced an average 1-year return of +19.1%. History favors the patient buyer here.

Quality Signals

💥 Capitulation Volume

No quality flags detected. This stock crossed below the line without any of our positive quality signals — approach with extra caution.

Things to Watch

  • No quality floor: This stock doesn't pass our Buffett quality screen or have a long dividend track record. The business quality is less certain, which means the 200-week MA crossing carries less predictive weight.
  • The 200-week moving average is a starting point, not a buy signal. Always research the company's fundamentals, competitive position, and recent news before acting.
View full MGEE analysis →

HSIC — Henry Schein, Inc.

Healthcare - Medical Distribution $8.1B
3.8% below $70.82 → 200WMA $73.62

Historical Context

This is the 25th time HSIC has crossed below its 200-week moving average. Previous crossings produced an average 1-year return of +12.3%. History favors the patient buyer here.

Quality Signals

🔍 Insider Buying

Things to Watch

  • No quality floor: This stock doesn't pass our Buffett quality screen or have a long dividend track record. The business quality is less certain, which means the 200-week MA crossing carries less predictive weight.
  • The 200-week moving average is a starting point, not a buy signal. Always research the company's fundamentals, competitive position, and recent news before acting.
View full HSIC analysis →

EPM — Evolution Petroleum Corporation

Energy - Oil & Gas E&P $163M
3.5% below $4.65 → 200WMA $4.82

Historical Context

This is the 23th time EPM has crossed below its 200-week moving average. Previous crossings produced an average 1-year return of +7%. History favors the patient buyer here.

Quality Signals

No quality flags detected. This stock crossed below the line without any of our positive quality signals — approach with extra caution.

Things to Watch

  • RSI still elevated (67): The stock just crossed below the line but isn't oversold yet. It may have further to fall before reaching a bottom.
  • Cycling pattern: EPM has crossed below the 200-week MA 23 times with modest average returns. This stock may oscillate around the line rather than bounce decisively — consider whether this is a value trap.
  • No quality floor: This stock doesn't pass our Buffett quality screen or have a long dividend track record. The business quality is less certain, which means the 200-week MA crossing carries less predictive weight.
  • The 200-week moving average is a starting point, not a buy signal. Always research the company's fundamentals, competitive position, and recent news before acting.
View full EPM analysis →

SSP — The E.W. Scripps Company

Communication Services - Broadcasting $415M
3% below $4.53 → 200WMA $4.68

Historical Context

This is the 28th time SSP has crossed below its 200-week moving average. Previous crossings produced an average 1-year return of +2.5%. History favors the patient buyer here.

Quality Signals

🎯 Yartseva Multibagger 🔍 Insider Buying 💰 21.2% FCF Yield ⚠️ FCF Declining 🔄 Frequent Crosser — Weak Recoveries

Things to Watch

  • RSI still elevated (62): The stock just crossed below the line but isn't oversold yet. It may have further to fall before reaching a bottom.
  • Cash flow is deteriorating: Free cash flow is trending downward. The stock might be cheap for a reason — verify whether this is a temporary or structural issue.
  • Cycling pattern: SSP has crossed below the 200-week MA 28 times with modest average returns. This stock may oscillate around the line rather than bounce decisively — consider whether this is a value trap.
  • No quality floor: This stock doesn't pass our Buffett quality screen or have a long dividend track record. The business quality is less certain, which means the 200-week MA crossing carries less predictive weight.
  • The 200-week moving average is a starting point, not a buy signal. Always research the company's fundamentals, competitive position, and recent news before acting.
View full SSP analysis →

QRVO — Qorvo Inc.

Technology - Semiconductors $7.9B
2.5% below $90.53 → 200WMA $92.90

Historical Context

This is the 5th time QRVO has crossed below its 200-week moving average. Previous crossings produced an average 1-year return of +39.7%. History favors the patient buyer here.

Quality Signals

💰 6.8% FCF Yield ⚠️ FCF Declining

Things to Watch

  • RSI still elevated (64): The stock just crossed below the line but isn't oversold yet. It may have further to fall before reaching a bottom.
  • Cash flow is deteriorating: Free cash flow is trending downward. The stock might be cheap for a reason — verify whether this is a temporary or structural issue.
  • No quality floor: This stock doesn't pass our Buffett quality screen or have a long dividend track record. The business quality is less certain, which means the 200-week MA crossing carries less predictive weight.
  • The 200-week moving average is a starting point, not a buy signal. Always research the company's fundamentals, competitive position, and recent news before acting.
View full QRVO analysis →

TRMB — Trimble Inc.

Technology - Scientific & Technical Instruments $14.2B
2.2% below $60.78 → 200WMA $62.18

Historical Context

This is the 25th time TRMB has crossed below its 200-week moving average. Previous crossings produced an average 1-year return of +8.1%. History favors the patient buyer here.

Quality Signals

No quality flags detected. This stock crossed below the line without any of our positive quality signals — approach with extra caution.

Things to Watch

  • Cycling pattern: TRMB has crossed below the 200-week MA 25 times with modest average returns. This stock may oscillate around the line rather than bounce decisively — consider whether this is a value trap.
  • No quality floor: This stock doesn't pass our Buffett quality screen or have a long dividend track record. The business quality is less certain, which means the 200-week MA crossing carries less predictive weight.
  • The 200-week moving average is a starting point, not a buy signal. Always research the company's fundamentals, competitive position, and recent news before acting.
View full TRMB analysis →

PCG — PG&E Corporation

Utilities - Utilities - Regulated Electric $35.4B
2% below $16.07 → 200WMA $16.40

Historical Context

This is the 31th time PCG has crossed below its 200-week moving average. Previous crossings produced an average 1-year return of +7.9%. History favors the patient buyer here.

Quality Signals

No quality flags detected. This stock crossed below the line without any of our positive quality signals — approach with extra caution.

Things to Watch

  • RSI still elevated (54): The stock just crossed below the line but isn't oversold yet. It may have further to fall before reaching a bottom.
  • Cycling pattern: PCG has crossed below the 200-week MA 31 times with modest average returns. This stock may oscillate around the line rather than bounce decisively — consider whether this is a value trap.
  • No quality floor: This stock doesn't pass our Buffett quality screen or have a long dividend track record. The business quality is less certain, which means the 200-week MA crossing carries less predictive weight.
  • The 200-week moving average is a starting point, not a buy signal. Always research the company's fundamentals, competitive position, and recent news before acting.
View full PCG analysis →

OXY — Occidental Petroleum Corporation

Energy - Oil & Gas $52.7B
1.6% below $53.03 → 200WMA $53.91

Historical Context

This is the 36th time OXY has crossed below its 200-week moving average. Previous crossings produced an average 1-year return of +11.8%. History favors the patient buyer here.

Quality Signals

💰 5.8% FCF Yield ⚠️ FCF Declining

Things to Watch

  • RSI still elevated (59): The stock just crossed below the line but isn't oversold yet. It may have further to fall before reaching a bottom.
  • Cash flow is deteriorating: Free cash flow is trending downward. The stock might be cheap for a reason — verify whether this is a temporary or structural issue.
  • No quality floor: This stock doesn't pass our Buffett quality screen or have a long dividend track record. The business quality is less certain, which means the 200-week MA crossing carries less predictive weight.
  • The 200-week moving average is a starting point, not a buy signal. Always research the company's fundamentals, competitive position, and recent news before acting.
View full OXY analysis →

AQN — Algonquin Power & Utilities Corp.

Utilities - Renewable & Electric $4.7B
1.6% below $6.07 → 200WMA $6.17

Historical Context

This is the third time AQN has crossed below its 200-week moving average. Previous crossings produced an average 1-year return of -41%. History has not rewarded buying this stock at the 200-week line — extra caution warranted.

Quality Signals

🔄 Frequent Crosser — Weak Recoveries

No quality flags detected. This stock crossed below the line without any of our positive quality signals — approach with extra caution.

Things to Watch

  • No quality floor: This stock doesn't pass our Buffett quality screen or have a long dividend track record. The business quality is less certain, which means the 200-week MA crossing carries less predictive weight.
  • The 200-week moving average is a starting point, not a buy signal. Always research the company's fundamentals, competitive position, and recent news before acting.
View full AQN analysis →

INGR — Ingredion Incorporated

Consumer Defensive - Packaged Foods $6.8B
1.3% below $107.39 → 200WMA $108.76

Historical Context

This is the 18th time INGR has crossed below its 200-week moving average. Previous crossings produced an average 1-year return of +22%. History favors the patient buyer here.

Quality Signals

🏆 Buffett Quality 💰 5.3% FCF Yield

Things to Watch

  • The 200-week moving average is a starting point, not a buy signal. Always research the company's fundamentals, competitive position, and recent news before acting.
View full INGR analysis →

MELI — MercadoLibre Inc.

Consumer Discretionary - E-Commerce $82.8B
1.3% below $1632.52 → 200WMA $1653.42

Historical Context

This is the 10th time MELI has crossed below its 200-week moving average. Previous crossings produced an average 1-year return of +52.1%. History favors the patient buyer here.

Quality Signals

📈 FCF Growing 📉 RSI 28 (Oversold) 💥 Capitulation Volume

Things to Watch

  • Oversold (RSI 28): The stock is already deeply oversold on a weekly basis. This could mean a bounce is near, but it could also mean momentum is strongly negative. Don't catch a falling knife without a thesis.
  • No quality floor: This stock doesn't pass our Buffett quality screen or have a long dividend track record. The business quality is less certain, which means the 200-week MA crossing carries less predictive weight.
  • The 200-week moving average is a starting point, not a buy signal. Always research the company's fundamentals, competitive position, and recent news before acting.
View full MELI analysis →

WDFC — WD-40 Company

Consumer Staples - Household Products $2.8B
1.2% below $208.05 → 200WMA $210.69

Historical Context

This is the 35th time WDFC has crossed below its 200-week moving average. Previous crossings produced an average 1-year return of +20.1%. History favors the patient buyer here.

Quality Signals

🏆 Buffett Quality ⚠️ FCF Declining

Things to Watch

  • Cash flow is deteriorating: Free cash flow is trending downward. The stock might be cheap for a reason — verify whether this is a temporary or structural issue.
  • The 200-week moving average is a starting point, not a buy signal. Always research the company's fundamentals, competitive position, and recent news before acting.
View full WDFC analysis →

GGG — Graco Inc.

Industrials - Fluid Handling $12.9B
1% below $77.59 → 200WMA $78.34

Historical Context

This is the 23th time GGG has crossed below its 200-week moving average. Previous crossings produced an average 1-year return of +43.5%. History favors the patient buyer here.

Quality Signals

🏆 Buffett Quality 📈 FCF Growing

Things to Watch

  • The 200-week moving average is a starting point, not a buy signal. Always research the company's fundamentals, competitive position, and recent news before acting.
View full GGG analysis →

PNR — Pentair plc

Industrials - Specialty Industrial Machinery $12.4B
0.9% below $76.82 → 200WMA $77.49

Historical Context

This is the 47th time PNR has crossed below its 200-week moving average. Previous crossings produced an average 1-year return of +9%. History favors the patient buyer here.

Quality Signals

👑 Dividend Aristocrat 📈 FCF Growing 📉 RSI 23 (Oversold) 📉 Distribution

Things to Watch

  • Oversold (RSI 23): The stock is already deeply oversold on a weekly basis. This could mean a bounce is near, but it could also mean momentum is strongly negative. Don't catch a falling knife without a thesis.
  • Cycling pattern: PNR has crossed below the 200-week MA 47 times with modest average returns. This stock may oscillate around the line rather than bounce decisively — consider whether this is a value trap.
  • The 200-week moving average is a starting point, not a buy signal. Always research the company's fundamentals, competitive position, and recent news before acting.
View full PNR analysis →

LDOS — Leidos Holdings Inc.

Industrials - Defense IT $16.4B
0.5% below $130.11 → 200WMA $130.80

Historical Context

This is the 13th time LDOS has crossed below its 200-week moving average. Previous crossings produced an average 1-year return of +10.5%. History favors the patient buyer here.

Quality Signals

📈 FCF Growing 💰 7.3% FCF Yield 📉 RSI 19 (Oversold)

Things to Watch

  • Oversold (RSI 19): The stock is already deeply oversold on a weekly basis. This could mean a bounce is near, but it could also mean momentum is strongly negative. Don't catch a falling knife without a thesis.
  • No quality floor: This stock doesn't pass our Buffett quality screen or have a long dividend track record. The business quality is less certain, which means the 200-week MA crossing carries less predictive weight.
  • The 200-week moving average is a starting point, not a buy signal. Always research the company's fundamentals, competitive position, and recent news before acting.
View full LDOS analysis →

PG — The Procter & Gamble Company

Consumer Staples - Household Products $341.0B
0.4% below $146.42 → 200WMA $147.02

Historical Context

This is the 32th time PG has crossed below its 200-week moving average. Previous crossings produced an average 1-year return of +14%. History favors the patient buyer here.

Quality Signals

👑 Dividend Aristocrat 📈 FCF Growing

Things to Watch

  • The 200-week moving average is a starting point, not a buy signal. Always research the company's fundamentals, competitive position, and recent news before acting.
View full PG analysis →

ATNI — ATN International, Inc.

Communication Services - Telecom Services $408M
0.3% below $26.55 → 200WMA $26.64

Historical Context

This is the 25th time ATNI has crossed below its 200-week moving average. Previous crossings produced an average 1-year return of +20.6%. History favors the patient buyer here.

Quality Signals

🎯 Yartseva Multibagger 💰 13.8% FCF Yield

Things to Watch

  • RSI still elevated (57): The stock just crossed below the line but isn't oversold yet. It may have further to fall before reaching a bottom.
  • No quality floor: This stock doesn't pass our Buffett quality screen or have a long dividend track record. The business quality is less certain, which means the 200-week MA crossing carries less predictive weight.
  • The 200-week moving average is a starting point, not a buy signal. Always research the company's fundamentals, competitive position, and recent news before acting.
View full ATNI analysis →

IR — Ingersoll Rand Inc.

Industrials - Machinery $29.6B
0.1% below $75.75 → 200WMA $75.85

Historical Context

This is the 6th time IR has crossed below its 200-week moving average. Previous crossings produced an average 1-year return of +62.5%. History favors the patient buyer here.

Quality Signals

No quality flags detected. This stock crossed below the line without any of our positive quality signals — approach with extra caution.

Things to Watch

  • No quality floor: This stock doesn't pass our Buffett quality screen or have a long dividend track record. The business quality is less certain, which means the 200-week MA crossing carries less predictive weight.
  • The 200-week moving average is a starting point, not a buy signal. Always research the company's fundamentals, competitive position, and recent news before acting.
View full IR analysis →

BLCO — Bausch + Lomb Corporation

Healthcare - Medical Instruments & Supplies $5.8B
0% below $16.18 → 200WMA $16.19

Historical Context

This is the 5th time BLCO has crossed below its 200-week moving average. Previous crossings produced an average 1-year return of +4.4%. History favors the patient buyer here.

Quality Signals

⚠️ FCF Declining 🔄 Frequent Crosser — Weak Recoveries

No quality flags detected. This stock crossed below the line without any of our positive quality signals — approach with extra caution.

Things to Watch

  • Cash flow is deteriorating: Free cash flow is trending downward. The stock might be cheap for a reason — verify whether this is a temporary or structural issue.
  • Cycling pattern: BLCO has crossed below the 200-week MA 5 times with modest average returns. This stock may oscillate around the line rather than bounce decisively — consider whether this is a value trap.
  • No quality floor: This stock doesn't pass our Buffett quality screen or have a long dividend track record. The business quality is less certain, which means the 200-week MA crossing carries less predictive weight.
  • The 200-week moving average is a starting point, not a buy signal. Always research the company's fundamentals, competitive position, and recent news before acting.
View full BLCO analysis →

📈 Recovered Above the Line

These stocks climbed back above their 200-week moving average this week. If you bought during their time below the line, this is a milestone — though not necessarily a sell signal.

VFC
VF Corporation
0.1% above · $18.98
LE
Lands' End, Inc.
0.1% above · $11.53
AVNT
Avient Corporation
0.3% above · $36.89
AWR
American States Water Company
0.3% above · $77.20
QS
QuantumScape Corporation
0.8% above · $7.54
IFF
International Flavors & Fragrances Inc.
0.9% above · $81.05
IRT
Independence Realty Trust, Inc.
1% above · $16.43
UDR
UDR, Inc.
1% above · $36.91
SONY
Sony Group Corporation
1.1% above · $20.15
GDEN
Golden Entertainment, Inc.
1.2% above · $28.55
CRSP
CRISPR Therapeutics AG
1.4% above · $54.83
YMM
Full Truck Alliance Co. Ltd.
1.8% above · $8.81
MDB
MongoDB Inc.
2.9% above · $299.47
BLFS
BioLife Solutions, Inc.
3.1% above · $22.04
NNE
NANO Nuclear Energy Inc.
3.3% above · $27.45
VKTX
Viking Therapeutics, Inc.
3.6% above · $31.33
LEGH
Legacy Housing Corporation
4.3% above · $23.28
ARES
Ares Management Corporation
4.8% above · $126.25
SOLV
Solventum Corporation
4.9% above · $73.38
CAMP
CAMP4 THERAPEUTICS CORPORATION
5.2% above · $4.46
CVGI
Commercial Vehicle Group, Inc.
5.9% above · $5.10
WAT
Waters Corporation
9.2% above · $355.13
RXO
RXO, Inc.
9.8% above · $21.75
DOC
Healthpeak Properties, Inc.
10.1% above · $19.64
ALGT
Allegiant Travel Company
10.3% above · $83.03
DBX
Dropbox Inc.
12.2% above · $28.90
WMG
Warner Music Group Corp.
13.1% above · $33.36
HZO
MarineMax, Inc.
15.2% above · $34.32
CCSI
Consensus Cloud Solutions, Inc.
16.1% above · $34.00
MIDD
The Middleby Corporation
17% above · $164.67
LXRX
Lexicon Pharmaceuticals, Inc.
20.3% above · $2.00
EVER
EverQuote, Inc.
22.9% above · $20.50
FLNC
Fluence Energy, Inc.
41.2% above · $24.16

Not financial advice. This is an educational tool. Past performance does not guarantee future results. Do your own research before making investment decisions.